Litigation / Derivative Actions
Derivative actions are an important tool in the enforcement of proper corporate governance in companies in Israel.
In recent years, the use of derivative actions has increasingly become a key concern for private and public companies.
Our firm has substantial knowledge and expertise in advising companies, officers, and shareholders on derivative actions.
The litigation team at Barne Jaffa Lande Law Offices has gained in-depth experience in representing clients in securities law disputes, control fights, lawsuits against officers and shareholders, minority oppression lawsuits, shareholders’ disputes, and business-related lawsuits.
Our Litigation Department handles, inter alia, lawsuits alleging breaches of fiduciary duties of trust and care toward a company, erroneous or misleading financials and reports, noncompliance with reporting obligations, unlawful trading using insider information, restatements of financial statements, and more.
The experience and knowledge we’ve accumulated, combined with our savvy business mindset, enable us to successfully manage any type of derivative action proceeding.
Insights & News - Litigation / Derivative Actions:
Activist Shareholders – The Israeli Challenge
Barnea and ACC hosted today a seminar on shareholder activism. Micky Barnea discussed activism in Israeli companies. Also presenting were Elchanan (Nani) Maoz from Everest Fund and Steve Wolosky from Olshan Frome Wolosky LLP.
Israeli Court Scrutiny Over Decisions of a Board of an Israeli NASDAQ Traded Company in a Proxy Fight
Recently, a four month proxy fight over control of an Israeli incorporated NASDAQ traded company was settled, following a series of proceedings held before the Tel Aviv District Court. At a crucial juncture, the Tel Aviv Court was asked to issue a temporary injunction over a transaction initiated by the board, which included a highly dilutive (24.9%) issuance of shares.
Landmark Israeli Court Decision Halts Deal between Two US Companies
An Israeli court has ordered to halt an investment deal in Arcturus Therapeutics, pending clarification of the lawsuit filed by Joseph Payne, the company's founder, regarding the cancellation of his dismissal as CEO. This decision was made despite the fact that the company operates in the United States with American management. Joseph Payne is represented by Advs. Micky Barnea, Zohar Lande, Omer Keydar, and Ron Shuhatovich.
Litigation / Derivative Actions
Derivative actions are an important tool in the enforcement of proper corporate governance in companies in Israel.
In recent years, the use of derivative actions has increasingly become a key concern for private and public companies.
Our firm has substantial knowledge and expertise in advising companies, officers, and shareholders on derivative actions.
The litigation team at Barne Jaffa Lande Law Offices has gained in-depth experience in representing clients in securities law disputes, control fights, lawsuits against officers and shareholders, minority oppression lawsuits, shareholders’ disputes, and business-related lawsuits.
Our Litigation Department handles, inter alia, lawsuits alleging breaches of fiduciary duties of trust and care toward a company, erroneous or misleading financials and reports, noncompliance with reporting obligations, unlawful trading using insider information, restatements of financial statements, and more.
The experience and knowledge we’ve accumulated, combined with our savvy business mindset, enable us to successfully manage any type of derivative action proceeding.
Insights & News - Litigation:
Activist Shareholders – The Israeli Challenge
Barnea and ACC hosted today a seminar on shareholder activism. Micky Barnea discussed activism in Israeli companies. Also presenting were Elchanan (Nani) Maoz from Everest Fund and Steve Wolosky from Olshan Frome Wolosky LLP.
Israeli Court Scrutiny Over Decisions of a Board of an Israeli NASDAQ Traded Company in a Proxy Fight
Recently, a four month proxy fight over control of an Israeli incorporated NASDAQ traded company was settled, following a series of proceedings held before the Tel Aviv District Court. At a crucial juncture, the Tel Aviv Court was asked to issue a temporary injunction over a transaction initiated by the board, which included a highly dilutive (24.9%) issuance of shares.
Landmark Israeli Court Decision Halts Deal between Two US Companies
An Israeli court has ordered to halt an investment deal in Arcturus Therapeutics, pending clarification of the lawsuit filed by Joseph Payne, the company's founder, regarding the cancellation of his dismissal as CEO. This decision was made despite the fact that the company operates in the United States with American management. Joseph Payne is represented by Advs. Micky Barnea, Zohar Lande, Omer Keydar, and Ron Shuhatovich.